Supplements

What Causes Joint Pain with Endometriosis?

Up to 70% of women with endometriosis report musculoskeletal pain beyond the pelvis — including aching, swollen, or stiff joints. The mechanism isn't coincidental. Systemic inflammatory cytokines, estrogen-driven immune dysregulation, and central sensitization all extend endometriosis pain well outside the reproductive system.

Jared Murray ·Co-Founder & Head of Health Research, Ones · ·9 min read
endometriosisjoint paininflammationestrogen dominanceomega-3prostaglandins
What Causes Joint Pain with Endometriosis?

What Causes Joint Pain with Endometriosis?

Yes, endometriosis can cause joint pain, and it's more common than most clinicians acknowledge. The primary drivers are systemic inflammation — particularly elevated prostaglandins and pro-inflammatory cytokines like IL-6 and TNF-α — plus estrogen-driven immune dysregulation that lowers the pain threshold throughout the body. The main caveat: joint pain severity doesn't always track with lesion severity, which is why some people with minimal visible disease experience debilitating musculoskeletal symptoms.

Why Endometriosis Is a Whole-Body Inflammatory Disease

Endometriosis is frequently described as a gynecological condition, but the inflammatory cascade it generates is systemic. Ectopic endometrial tissue secretes prostaglandins, matrix metalloproteinases (MMPs), and cytokines that enter circulation — affecting tissues far from the pelvis, including synovial membranes in joints.

A landmark analysis published in Human Reproduction Update found that women with endometriosis have significantly elevated peritoneal and serum concentrations of IL-1β, IL-6, IL-8, and TNF-α compared to controls (Zondervan et al., Human Reproduction Update 2020; PMID: 31603258). These same cytokines are well-established mediators of inflammatory arthritis and joint degradation. When they circulate chronically — as they do in active endometriosis — joint tissues become collateral targets.

Estrogen amplifies this further. Estrogen promotes the differentiation of pro-inflammatory Th17 cells while suppressing regulatory T-cells (Tregs) that normally dampen immune responses (Hewagama et al., J Autoimmun 2009; PMID: 19356896). In estrogen-dominant states — which endometriosis frequently creates — this immune imbalance becomes self-perpetuating. The result is a low-grade but chronic inflammatory environment that sensitizes pain receptors throughout the musculoskeletal system.

This whole-body picture is why joint pain in endometriosis is not simply referred pelvic pain — it has distinct inflammatory mechanisms driving it.

The Prostaglandin–Joint Pain Connection

Prostaglandin E2 (PGE2) is one of the most potent drivers of both endometriosis lesion growth and peripheral joint pain. Ectopic endometrial cells overexpress cyclooxygenase-2 (COX-2), the enzyme that synthesizes PGE2, at levels significantly higher than eutopic endometrium (Ota et al., Fertility and Sterility 2001; PMID: 11384643).

Elevated PGE2 does several things simultaneously:

  • Sensitizes peripheral nociceptors (pain-sensing nerve endings in joint capsules and synovium)
  • Promotes synovial inflammation directly
  • Upregulates aromatase in peripheral tissues, increasing local estrogen production — creating a feed-forward loop
  • Suppresses ovulation and alters the hormonal environment further

This explains why NSAIDs (which inhibit COX-2 and reduce PGE2) provide partial joint pain relief for some people with endometriosis — but also why they don't fully resolve it, since the upstream inflammatory drivers remain active.

Omega-3 fatty acids — specifically EPA and DHA — compete with arachidonic acid for COX-2 access, shifting prostaglandin production toward less inflammatory series-3 prostaglandins. A randomized controlled trial in adolescents with dysmenorrhea found that fish oil supplementation significantly reduced pain scores compared to placebo, with effects comparable to low-dose ibuprofen over a three-month period (Harel et al., Am J Obstet Gynecol 1996; PMID: 8623866). While this trial focused on menstrual pain, the PGE2-modulation mechanism is directly relevant to joint pain driven by the same pathway.

Central Sensitization: Why Joint Pain Persists Even During Remission

One of the most underappreciated aspects of endometriosis-related joint pain is central sensitization — a state in which the central nervous system becomes hyperresponsive to pain signals. After months or years of chronic pelvic and musculoskeletal pain, the spinal cord and brain essentially turn up the gain on pain processing.

Research using quantitative sensory testing has demonstrated that women with endometriosis show significantly lower pressure pain thresholds at distant body sites — including the knee and shoulder — compared to pain-free controls, even when controlling for pelvic tenderness (As-Sanie et al., Obstetrics & Gynecology 2014; PMID: 25415165). This means joint pain can persist or worsen even when endometriosis lesions are surgically removed or suppressed hormonally, because the nervous system has been recalibrated.

Central sensitization also helps explain the high overlap between endometriosis and conditions like fibromyalgia, hypermobility spectrum disorders, and widespread musculoskeletal pain — all of which involve amplified central pain processing.

For practitioners and patients alike, this has real implications: treating joint pain from endometriosis requires addressing both the peripheral inflammatory source and the central nervous system component. Supplements and interventions that support nerve resilience and reduce neuroinflammation — including magnesium, omega-3s, and adaptogenic herbs that modulate the HPA axis — become relevant here.

Estrogen Dominance, Immune Dysregulation, and Connective Tissue

Estrogen doesn't just fuel inflammation — it directly affects connective tissue integrity. Estrogen receptors are expressed throughout ligaments, tendons, and cartilage. During phases of high estrogen (or in estrogen-dominant states without sufficient progesterone opposition), connective tissue becomes more lax and injury-prone.

This hormonal dynamic is part of why joint pain patterns in conditions like PCOS and PMDD share mechanistic overlap with endometriosis — estrogen signaling affects connective tissue across all these conditions, though the inflammatory backdrop differs. Similarly, adenomyosis, which often co-occurs with endometriosis, compounds the systemic inflammatory burden through a parallel mechanism.

In endometriosis specifically, aberrant immune surveillance allows ectopic tissue to implant and survive outside the uterus — a process driven partly by impaired natural killer (NK) cell activity. NK cells that fail to clear ectopic implants allow the inflammatory cycle to continue unchecked. Nutritional factors that support NK cell function — including zinc, vitamin D3, and selenium — may play a supporting role in modulating this immune dysregulation, though randomized trials specifically in endometriosis are still limited.

Vitamin D3 deserves particular attention. Vitamin D receptors are expressed on immune cells, and deficiency correlates with higher disease severity in endometriosis. A systematic review found that women with endometriosis had significantly lower serum 25-hydroxyvitamin D levels than controls, and that supplementation was associated with reductions in inflammatory markers (Harris et al., J Endometr Pelvic Pain Disord 2017). Vitamin D3 combined with K2 (MK-7) supports both immune regulation and bone/joint integrity — particularly relevant when estrogen suppression therapies (like GnRH agonists) are used, which accelerate bone turnover.

Key Biomarkers to Track

If you have endometriosis and are experiencing joint pain, tracking the right biomarkers gives you a mechanistic window into what's driving it and whether interventions are working.

BiomarkerWhat It ReflectsOptimal Target
hs-CRPSystemic inflammation< 1.0 mg/L
IL-6 (serum)Active inflammatory signaling< 1.8 pg/mL
Estradiol (E2)Estrogen status and cycling patternContext-dependent
ProgesteroneEstrogen-progesterone balanceAdequate luteal phase levels
25-OH Vitamin DImmune regulation and bone protection50–80 ng/mL
FerritinInflammatory iron sequestration vs. true deficiency50–100 ng/mL (functional)
Omega-3 IndexEPA+DHA as % of red blood cell fatty acids> 8%

Elevated hs-CRP and low omega-3 index together are a particularly actionable combination — both respond meaningfully to dietary and supplemental omega-3 intervention within 8–12 weeks.

A Practical Protocol for Endometriosis Joint Pain

Managing joint pain from endometriosis requires a layered approach that targets inflammation, hormone balance, and nervous system support simultaneously.

  1. Optimize omega-3 intake: Aim for 2–3g combined EPA+DHA daily from high-quality fish oil. This dosage range is supported by anti-inflammatory outcomes in multiple RCTs and directly targets the PGE2 pathway implicated in endometriosis joint pain.
  2. Address vitamin D status: Get serum 25-OH vitamin D tested. If below 40 ng/mL, supplementation with D3 + K2 (MK-7) supports both immune regulation and musculoskeletal protection. Standard repletion doses range from 2,000–5,000 IU D3 daily depending on baseline levels.
  3. Support magnesium status: Magnesium is a cofactor for over 300 enzymatic reactions and plays a direct role in muscle and nerve function. Magnesium deficiency is common in people with chronic pain and high inflammatory load. Magnesium glycinate is well-absorbed and least likely to cause GI side effects at therapeutic doses (300–400 mg elemental magnesium daily).
  4. Reduce dietary arachidonic acid load: Limit red meat and processed vegetable oils high in omega-6 fats, which provide the substrate for PGE2 synthesis.
  5. Consider HPA axis support: Chronic pain chronically activates the stress axis. Adaptogens like Rhodiola rosea and ashwagandha (KSM-66) have evidence for reducing cortisol and neuroinflammation, which may reduce central sensitization over time — though direct endometriosis trials are lacking.
  6. Track and test, don't guess: Baseline hs-CRP and omega-3 index give you objective markers to measure response over 90 days.

What This Means for Your Formula

Endometriosis-related joint pain is multi-mechanistic, which means no single supplement addresses it fully. Ones analyzes blood markers — including inflammatory markers, vitamin D, and fatty acid status where available — alongside health history to identify which drivers are most active for a specific individual.

For someone with endometriosis and joint pain, a Ones formula would likely incorporate:

  • Omega-3 (EPA/DHA) at a clinically meaningful dose to shift the prostaglandin balance away from pro-inflammatory PGE2 — directly targeting the COX-2 pathway overactive in ectopic endometrial tissue
  • Vitamin D3 + K2 (MK-7) to support immune regulation and protect musculoskeletal integrity, particularly important if hormonal suppression therapy is in use
  • Ligament Support (a proprietary Ones System Blend) designed to support connective tissue, which becomes relevant given estrogen's effects on joint laxity and the structural component of musculoskeletal pain in endometriosis

The Ones AI doesn't prescribe a treatment for endometriosis — it identifies the nutritional gaps and inflammatory patterns visible in your data and builds a formula calibrated to those specific findings, within a 6 or 9-capsule daily plan.

Key Takeaways

  • Endometriosis causes joint pain through systemic inflammatory cytokines (IL-6, TNF-α), excess prostaglandin E2, and central nervous system sensitization — not just referred pelvic pain
  • Elevated COX-2 expression in ectopic endometrial tissue drives PGE2 overproduction, which directly sensitizes joint nociceptors and promotes synovial inflammation
  • Central sensitization explains why joint pain can persist even after lesions are surgically removed — the nervous system has been recalibrated toward higher pain sensitivity
  • Estrogen dominance lowers connective tissue integrity and suppresses immune surveillance, compounding musculoskeletal vulnerability
  • Key biomarkers to track: hs-CRP, 25-OH vitamin D, omega-3 index, and estradiol/progesterone ratio
  • Omega-3 fatty acids, vitamin D3 + K2, and magnesium glycinate are among the most evidence-supported nutritional interventions targeting the inflammatory and structural mechanisms driving endometriosis joint pain

---

Always consult a licensed healthcare provider before beginning any supplement regimen, particularly if you are taking hormonal therapies or NSAIDs for endometriosis management.

Written by Jared Murray, Co-Founder & Head of Health Research, Ones.

Jared is the co-founder and head of health research at Ones, with 25 years applying nutrition science, biomarker interpretation, and clinical supplementation research to individual health programs. He leads the editorial process for the Ones Health Library, where lab data, wearable biometrics, and peer-reviewed clinical research are translated into evidence-based, personalized supplement guidance.

Disclosure: Ones formulates and sells personalized supplements that may include ingredients discussed in this article. We have a financial interest in the products mentioned. Recommendations are based on published research and our editorial standards, not sales targets.

This article is educational content, not medical advice. Consult a healthcare provider before changing your supplement regimen.

Further reading

Related reading